Clinical Trial Update: Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic Syndrome [Phase 3]

View source ↗

Summary

Completed Phase 3 trial assessing the efficacy and safety of rituximab compared with calcineurin inhibitors in children with steroid-dependent nephrotic syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Rituximab (rituximab)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Nilratan Sircar Medical College | Conditions: Nephrotic Syndrome | Phase 3 | Status: COMPLETED